Your browser doesn't support javascript.
loading
Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules.
Berkers, Celia R; de Jong, Annemieke; Schuurman, Karianne G; Linnemann, Carsten; Meiring, Hugo D; Janssen, Lennert; Neefjes, Jacques J; Schumacher, Ton N M; Rodenko, Boris; Ovaa, Huib.
Afiliación
  • Berkers CR; Division of Cell Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;
  • de Jong A; Division of Cell Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;
  • Schuurman KG; Division of Cell Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;
  • Linnemann C; Division of Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; and.
  • Meiring HD; Institute for Translational Vaccinology, 3721 MA Bilthoven, the Netherlands.
  • Janssen L; Division of Cell Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;
  • Neefjes JJ; Division of Cell Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;
  • Schumacher TN; Division of Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; and.
  • Rodenko B; Division of Cell Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands;
  • Ovaa H; Division of Cell Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; h.ovaa@nki.nl.
J Immunol ; 195(9): 4085-95, 2015 Nov 01.
Article en En | MEDLINE | ID: mdl-26401003
ABSTRACT
Peptide splicing, in which two distant parts of a protein are excised and then ligated to form a novel peptide, can generate unique MHC class I-restricted responses. Because these peptides are not genetically encoded and the rules behind proteasomal splicing are unknown, it is difficult to predict these spliced Ags. In the current study, small libraries of short peptides were used to identify amino acid sequences that affect the efficiency of this transpeptidation process. We observed that splicing does not occur at random, neither in terms of the amino acid sequences nor through random splicing of peptides from different sources. In contrast, splicing followed distinct rules that we deduced and validated both in vitro and in cells. Peptide ligation was quantified using a model peptide and demonstrated to occur with up to 30% ligation efficiency in vitro, provided that optimal structural requirements for ligation were met by both ligating partners. In addition, many splicing products could be formed from a single protein. Our splicing rules will facilitate prediction and detection of new spliced Ags to expand the peptidome presented by MHC class I Ags.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Péptidos / Antígenos de Histocompatibilidad Clase I / Presentación de Antígeno / Empalme de Proteína / Complejo de la Endopetidasa Proteasomal Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Immunol Año: 2015 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Péptidos / Antígenos de Histocompatibilidad Clase I / Presentación de Antígeno / Empalme de Proteína / Complejo de la Endopetidasa Proteasomal Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Immunol Año: 2015 Tipo del documento: Article